Business Description
Sana Biotechnology is a Seattle-based company working to treat serious diseases by engineering human cells and using them as medicines. Its main focus areas include type 1 diabetes, autoimmune diseases, and cancer, with several treatments currently in clinical and preclinical development. The company works with partners such as Beam Therapeutics and Harvard College to access cutting-edge technologies that help make its cell therapies more effective and compatible with a wider range of patients.